Overview

In this role you lead global value, access and pricing for the Neurology portfolio with a focus on NMOSD, shaping launch and lifecycle decisions across key EU markets. You work cross-functionally to align evidence generation, payer engagement, and pricing strategies with country inputs and HTA needs. You will influence senior leadership and drive patient access for transformative therapies in rare diseases. This position offers strategic visibility and tangible impact on market access at scale.

Responsabilidades

- Lead global market access, value and pricing strategies for Neurology indications, especially NMOSD, across key EU markets
- Develop differentiated value propositions and integrate evidence generation plans and RWE to reduce payer uncertainty and optimize access
- Support NMOSD lifecycle management through governance milestones and TPP requirements
- Create and roll out pricing communication tools and negotiation tools aligned with the enterprise launch framework
- Oversee updates to the global NMOSD reimbursement dossier and cross-functional readiness plans
- Represent GVAP strategy across Integral Value Sub-Team and Global Launch Team; provide updates to local teams
- Lead the Neurology payer working group to share evidence and best practices across countries




- Incorporate patient perspective into payer negotiations and strategies
- Develop, assess and inform pricing and reimbursement risks and opportunities for Neurology, with a focus on top EU markets
- Collaborate with country access representatives and HEOR/Medical/Commercial teams to ensure aligned access strategy

Requisitos principales

- Deep expertise in global payer, HTA, and reimbursement ecosystems
- Experience driving market access and pricing in rare diseases and Neurology
- Strong leadership and cross-functional collaboration skills
- Ability to translate science into payer value narratives for leadership and stakeholders
- 6+ years of relevant pharma/biotech drug development or commercialization experience
- Graduate degree in PhD, PharmD, Biomedical Sciences, business, or economics (noted as relevant)
- Knowledge of national/regional payer needs in strategic markets; experience in cost-effectiveness markets (UK, Canada, Nordics) preferred

- Strategic thinking
- Effective communication across cross-functional teams
- Influence without authority
- HTA and payer landscape knowledge
- Value proposition development
- RWE planning and integration

📌 Global Pricing & Access Lead, Rare Neurology (Barcelona)
🏢 Alexion Pharmaceuticals
📍 Barcelona